The Latest Cardiac and Vascular News
Proven sales leader brings more than 20 years of healthcare experience to help Implicity accelerate its expansion into the US market CAMBRIDGE, Mass., June 22, 2021 /PRNewswire/ — Implicity, a leader in remote patient monitoring software and cardiac data management solutions, today announced the addition of Tim Laird as Vice President of Sales–North America. Laird […]
Global Contract Research Organization (CRO) Avania to Manage All Regulatory Affairs in Connection with JanOne’s Phase 2b Trial Preparedness and Execution LAS VEGAS, June 22, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced its selection […]
Cell Therapy Platform Demonstrates High Dose CD34+ Cell Performance Characteristics in Patients with Ischemic Heart Failure SAN CARLOS, Calif., June 22, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces data from its CardiAMP […]
George Montague to serve as Chief Financial Officer and Neil P. Ayotte, to serve as General Counsel and Chief Compliance Officer EDEN PRAIRIE, Minn., June 22, 2021 (GLOBE NEWSWIRE) — Continuing its dynamic growth in support of its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric […]
June 22, 2021 First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI) procedures guided by iFR data co-registered on the angiogram (interventional X-ray image) versus the current standard of care, an angiogram alone One of the largest-ever […]
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) — Verve Therapeutics (Nasdaq: VERV), a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the closing of its previously announced initial public offering of 16,141,157 shares of its common stock, which includes 2,105,368 shares […]
Leading ECG analysis platform speeds time to diagnosis and creates greater clinical efficiencies with expanded software capabilities BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc. (“Cardiac Insight” or the “Company”) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) data to improve early detection and […]
BOSTON–(BUSINESS WIRE)–Imbria Pharmaceuticals, a clinical stage biopharmaceutical company developing novel therapies designed to enhance cellular energetics for the treatment of major forms of heart disease and specific inborn errors of metabolism, today announced that the first 10 (ten) patients were dosed in the IMPROVE-DiCE Phase 2a, open-label study of IMB-1018972 […]
Charlottesville, VA June 22, 2021 – Caretaker Medical, developer of the Caretaker™ Wireless Hemodynamic Patient Monitor has been selected for MedTech Innovator’s Annual Showcase and Accelerator for 2021. Caretaker Medical was selected from a field of over 1100 companies across 50 countries as one of the Top 50 MedTech firms […]
Novel Biodegradable Stent Technology Approved for Sale in Europe WINSEN, Germany, June 21, 2021 /PRNewswire/ — QualiMed Innovative Medizinprodukte GmbH, a wholly owned subsidiary of Dublin, Ireland based Q3 Medical Devices Limited (Q3), announced that it has received CE mark approval for a dedicated percutaneous biodegradable metal alloy based stent implant for biliary applications, the UNITY-B Percutaneous Balloon […]
